Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy

Journal of Cardiovascular Pharmacology

Volumn 45, Issue 3, 2005, Pages 204-210

  Kikuchi, Toshio ^a   Oka, Naoki ^a   Koga, Akimasa ^a   Miyazaki, Hiroshi ^a   Ohmura, Haruya ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenergic receptors; Calcium; Catecholamines; Caveolae; Caveolin; Hypertrophy

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCINEURIN INHIBITOR; CAVEOLIN 3; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; IONOMYCIN; PHENYLEPHRINE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CAVEOLA; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; HEART MUSCLE CELL; MALE; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANIMALS, NEWBORN; BLOTTING, NORTHERN; CARDIOMEGALY; CAVEOLAE; CAVEOLIN 3; CAVEOLINS; CELL SIZE; CELLS, CULTURED; IMMUNOBLOTTING; LEUCINE; MALE; MICROSCOPY, ELECTRON; MYOCYTES, CARDIAC; PHORBOL 12,13-DIBUTYRATE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 14744272442     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000152029.53997.57     Document Type: Article

References (30)

1. Okamoto T, Schlegel A, Scherer PE, et al. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem. 1998;273:5419-5422.
2. Anderson RG. The caveolae membrane system. Annu Rev Biochem. 1998;67:199-225.
3. Smart EJ, Graf GA, McNiven MA, et al. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol. 1999;19:7289-7304.
4. Ostrom RS, Post SR, Insel PA. Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s). J Pharmacol Exp Ther. 2000;294:407-412.
5. Song KS, Scherer PE, Tang Z, et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem. 1996;271:15160-15165.
6. Feron O, Belhassen L, Kobzik L, et al. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem. 1996;271:22810-22814.
7. Li S, Okamoto T, Chun M, et al. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem. 1995;270:15693-15701.
8. Oka N, Yamamoto M, Schwencke C, et al. Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem. 1997;272:33416-33421.
9. Mineo C, James GL, Smart EJ, et al. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem. 1996;271:11930-11935.
10. Liu P, Ying Y, Ko YG, et al. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem. 1996;271:10299-10303.
11. Engelman JA, Zhang XL, Razani B, et al. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J Biol Chem. 1999;274:32333-32341.
12. Simpson P, Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ Res. 1982;50:101-116.
13. Thaik CM, Calderone A, Takahashi N, et al. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest. 1995;96:1093-1099.
14. Koga A, Oka N, Kikuchi T, et al. Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy. Hypertension. 2003;42:213-219.
15. Limas CJ. Increased number of beta-adrenergic receptors in the hypertrophied myocardium. Biochim Biophys Acta. 1979;588:174-178.
16. 1-Adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res. 1996;78:737-749.
17. Smart EJ, Foster DC, Ying YS, et al. Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae. J Cell Biol. 1994;124:307-313.
18. Fujimoto T. Calcium pump of the plasma membrane is localized in caveolae. J Cell Biol. 1993;120:1147-1157.
19. 2+-dependent activation of endothelial nitric-oxide synthase. J Biol Chem. 1999;274:29529-29535.
20. 2+ waves preferentially originate at specific loci in caveolin-rich cell edges. Proc Natl Acad Sci USA. 1998;95:5009-5014.
21. Lohn M, Furstenau M, Sagach V, et al. Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ Res. 2000;87:1034-1039.
22. 2+ entry requires localization in cholesterol-rich domains. J Biol Chem. 2000;275:26530-26537.
23. Clerk A, Sugden PH. Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am J Cardiol. 1999;83:64H-69H.
24. Galbiati F, Volonte D, Engelman JA, et al. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J Biol Chem. 1999;274:30315-30321.
25. Herzig TC, Jobe SM, Aoki H, et al. Angiotensin II type 1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc Natl Acad Sci USA. 1997;94:7543-7548.
26. Biederer CH, Ries SJ, Moser M, et al. The basic helix-loop-helix transcription factors myogenin and Id2 mediate specific induction of caveolin-3 gene expression during embryonic development. J Biol Chem. 2000;275:26245-26251.
27. Carman CV, Lisanti MP, Benovic JL. Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem. 1999;274:8858-8864.
28. Woodman SE, Park DS, Cohen AW, et al. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem. 2002;277:38988-38997.
29. Minetti C, Sotgia F, Bruno C, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet. 1998;18:365-368.
30. Hare JM, Lofthouse RA, Juang GJ, et al. Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure. Circ Res. 2000;86:1085-1092.